Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01414335
Other study ID # Kyb10/09
Secondary ID
Status Completed
Phase N/A
First received August 9, 2011
Last updated August 10, 2011
Start date October 2009
Est. completion date September 2010

Study information

Verified date August 2011
Source Kyberg Vital GmbH
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effectiveness of a dietary supplement with high dosage of amino acids and vitamins in the treatment of acute and chronic infection of pharyngeal area known as common cold. T


Recruitment information / eligibility

Status Completed
Enrollment 145
Est. completion date September 2010
Est. primary completion date February 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

men and women with at least two episodes of common cold and infection of ear, nose and pharyngeal area.

Exclusion Criteria:

- people with severe infection like pneumonia, patients expecting an in-patient treatment during the trial, pregnant or breast feeding and people not able to understand the procedure of the treatment

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Common Cold
  • to Improve the Effectiveness of a Amino Acid Dietary Supplement in Chronic Pharyngeal Infections vs Placebo

Intervention

Dietary Supplement:
amino acid composition
one single pouch (13g) of amino acid mixture and vitamins diluted into 200 ml of still water. This solution was daily oral taken after a meal.
Other:
Placebo
placebo contained no amino acids and vitamins and was identical in appearance and solution properties.

Locations

Country Name City State
Germany Kyberg Vital - Doris Meister Oberhaching Bavaria

Sponsors (1)

Lead Sponsor Collaborator
Kyberg Vital GmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary outcome of efficacy For each study day,participants recorded in a diary rectal temperature, symptoms of sneezing, blocked nose or streaming eyes, whether they had problems to swollow and whether they had headache or pain in arms or legs. 3 month treatment No
Secondary outcome of efficacy Secondary outcome variables: feel the patient fit and able-bodied. 3 month treatment No